Prevalence and Signification of Antinuclear and Anticardiolipin Antibodies in Patients with Epilepsy
- 1 July 1997
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 103 (1) , 33-37
- https://doi.org/10.1016/s0002-9343(97)90046-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Molecular Characterization of Seizure-Related Genes Isolated by Differential ScreeningBiochemical and Biophysical Research Communications, 1996
- Electroconvulsive Seizure Increases the Expression of CREM (Cyclic AMP Response Element Modulator) and ICER (Inducible Cyclic AMP Early Repressor) in Rat BrainJournal of Neurochemistry, 1996
- Studies of IgG-Class Anticardiolipin Antibodies in Myasthenia GravisAutoimmunity, 1994
- Immunological Adverse Effects of AnticonvulsantsDrug Safety, 1993
- Immunological aspects of epilepsyBrain & Development, 1993
- Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndromeThe American Journal of Medicine, 1989
- Chlorpromazine‐induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosisAmerican Journal of Hematology, 1988
- Epilepsy: an early symptom of systemic lupus erythematosus.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Histone reactivity of drug‐induced antinuclear antibodiesArthritis & Rheumatism, 1981
- Immunoglobulin Levels and Autoantibodies in Epileptics on Long‐term Anticonvulsant TherapyActa Medica Scandinavica, 1977